Figure 2.
Cohort survival. PFS (A) and OS (B) for all patients treated with CD30.CAR-T cell therapy.

Cohort survival. PFS (A) and OS (B) for all patients treated with CD30.CAR-T cell therapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal